Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae

Antibiotics in development targeting protein synthesis

(2011) Joyce A. Sutcliffe   Annals of the New York Academy of Sciences

On the specificity of antibiotics targeting the large ribosomal subunit

(2011) Daniel N. Wilson   Annals of the New York Academy of Sciences

Resistance drives antibacterial drug development

(2011) Ursula Theuretzbacher   CURRENT OPINION IN PHARMACOLOGY

Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis

(2010) B. Llano-Sotelo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CEM-101 Activity against Gram-Positive Organisms

(2010) L. N. Woosley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates

(2010) David J. Farrell et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)

(2010) David J. Farrell et al.   JOURNAL OF INFECTION

Antibiotics that target protein synthesis

(2010) Lisa S. McCoy et al.   Wiley Interdisciplinary Reviews-RNA

Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages

(2009) S. Lemaire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms

(2009) P. McGhee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria

(2009) Shannon D. Putnam et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pathogens Resistant to Antibacterial Agents

(2009) Luke F. Chen et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA